We are live on
!
Find out more
EC
Enhancing Capital Portfolio holdings
AUM
$135M
1-Year Est. Return
25.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.65%
1 Year Est. Return
+25.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$5.55M
(+4.2%)
Cap. Flow
-$3.22M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
41.51%
Holding
94
New
2
Increased
20
Reduced
7
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$697K |
| 2 |
Preformed Line Products
PLPC
|
+$327K |
| 3 |
Thermo Fisher Scientific
TMO
|
+$243K |
| 4 |
Mastercard
MA
|
+$116K |
| 5 |
Amazon
AMZN
|
+$94.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.01M |
| 2 |
General Mills
GIS
|
+$772K |
| 3 |
Air Products & Chemicals
APD
|
+$709K |
| 4 |
Idaho Strategic Resources
IDR
|
+$633K |
| 5 |
UnitedHealth
UNH
|
+$624K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Financials | 14.9% |
| 3 | Utilities | 11.25% |
| 4 | Industrials | 10.83% |
| 5 | Healthcare | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Enterprise Products Partners
EPD
$83.1B
| $280K | 0.21% |
8,960
| – | – |
|
|
77
Thermo Fisher Scientific
TMO
$208B
| $253K | 0.19% |
+522
| New | +$243K |
|
78
Watsco Inc
WSO
$15B
| $249K | 0.18% |
617
-195
| -24% | -$83.4K |
|
79
PNC Financial Services
PNC
$99.7B
| $248K | 0.18% |
1,235
| – | – |
|
80
Clorox
CLX
$11.7B
| $247K | 0.18% |
2,000
| – | – |
|
81
Lamb Weston
LW
$7.13B
| $246K | 0.18% |
4,240
| – | – |
|
82
HEICO Corp
HEI
$49.3B
| $240K | 0.18% |
743
-57
| -7% | -$18.1K |
|
83
Southern Company
SO
$109B
| $237K | 0.17% |
2,500
| – | – |
|
84
M&T Bank
MTB
$36B
| $217K | 0.16% |
1,100
| – | – |
|
85
Analog Devices
ADI
$178B
| $217K | 0.16% |
882
| – | – |
|
86
PPG Industries
PPG
$26.2B
| $210K | 0.15% |
2,000
| – | – |
|
87
Chubb
CB
$139B
| $204K | 0.15% |
722
| – | – |
|
|
88
Air Products & Chemicals
APD
$65.1B
| – | – |
-2,514
| Closed | -$709K |
|
89
AutoZone
AZO
$50.1B
| – | – |
-70
| Closed | -$260K |
|
|
90
General Mills
GIS
$19.5B
| – | – |
-14,900
| Closed | -$772K |
|
91
Oneok
OKE
$57.2B
| – | – |
-5,249
| Closed | -$428K |
|
|
92
Pfizer
PFE
$141B
| – | – |
-41,600
| Closed | -$1.01M |
|
|
93
UnitedHealth
UNH
$381B
| – | – |
-2,000
| Closed | -$624K |
|
94
Vanguard Dividend Appreciation ETF
VIG
$111B
| – | – |
-1,400
| Closed | -$287K |
|
Similar funds
UOP
BGI
ICM
GEH
AV
SA
JAA
SG
Enhancing Capital's Q3 2025 Portfolio in Review
As of Q3 2025, Enhancing Capital held 94 positions worth $137M, up 4.2% from $131M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Enhancing Capital's Q3 2025 filing shows 2 new, 20 increased, 7 reduced and 7 closed positions. Its largest new stake was Preformed Line Products: 1,860 shares worth $365K. The largest sale was Pfizer, an estimated $1.01M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Utilities.
- Enhancing Capital's largest Q3 2025 buy was Preformed Line Products: 1,860 shares worth $365K.
- Enhancing Capital added most to NVIDIA in Q3 2025, an estimated $697K increase.
- Enhancing Capital's biggest Q3 2025 reduction was Idaho Strategic Resources, cutting an estimated $633K.
- Enhancing Capital fully exited Pfizer in Q3 2025, selling an estimated $1.01M.
- Enhancing Capital's ten largest holdings make up 42% of its $137M portfolio in Q3 2025.
- Enhancing Capital opened 2 new positions and closed 7 in Q3 2025.
- Enhancing Capital's portfolio value rose 4.2% quarter-over-quarter to $137M.
Based on Enhancing Capital's 13F filing for Q3 2025, filed 13 Nov 2025.